2020-12-29,   《HKEx》- 01093 CSPC PHARMA - MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 DECEMBER 2020 
2020-12-29,   《HKEx》- 01093 CSPC PHARMA - LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION 
2020-12-22," <Research Report>Daiwa Axes CSPC PHARMA (01093.HK) TP to $6.8, Restated Sell "
2020-12-18," *Daiwa Axes CSPC PHARMA (01093.HK) TP to $6.8, Restated Sell "
2020-12-15,"   《HKEx》- 01093 CSPC PHARMA - RESIGNATION OF NON-EXECUTIVE DIRECTOR AND INDEPENDENT NON-EXECUTIVE DIRECTOR, CHANGE OF COMPANY SECRETARY AND CHANGE OF BOARD COMMITTEES "
2020-12-15,   《HKEx》- 01093 CSPC PHARMA - INSIDE INFORMATION - ADJUSTMENT TO THE MEDICAL INSURANCE REIMBURSEMENT BASIS 
2020-12-15, HSI Widens Slide to Over 300 Pts; Wharf REIC/ CKH/ Casinos/ Geely Slip 3%-5% 
2020-12-04,"   《HKEx》- 01093 CSPC PHARMA - An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section "
2020-11-25,   《HKEx》- 01093 CSPC PHARMA - CONTINUING CONNECTED TRANSACTIONS - RENEWAL OF STEAM SUPPLY AGREEMENT 
2020-11-25,   《HKEx》- 01093 CSPC PHARMA - VOLUNTARY ANNOUNCEMENT - ABSTRACT OF CLINICAL TRIAL DATA OF MITOXANTRONE HYDROCHLORIDE LIPOSOME FOR RELAPSED OR REFRACTORY PERIPHERAL T-CELL LYMPHOMA AND EXTRANODAL NK/T-CELL LYMPHOMA PRESENTED AT 2020 ASH ANNUAL MEETING 
